04/07/2026
We’re excited to share that Precision Epigenomics has been featured in an article by AZBio!
It’s an honor to be recognized for our commitment to advancing affordable, early cancer detection through our innovative EPISEEK liquid biopsy test. We’re grateful for the opportunity to share our mission: to change the way cancer is detected, managed, and ultimately survived.
Thank you to AZBio for highlighting our company!
Precision Epigenomics focuses on addressing cancer by targeting epigenetic changes (i.e., DNA methylation) that drive tumor development, progression, and treatment resistance. While genetic mutations have long been a focus in oncology, epigenetic dysregulation plays a critical role in how cancer cel...